Czech Pharmaco-epidemiological Study on Disease Modifying Drugs

NCT05762003 · clinicaltrials.gov ↗

COMPLETED

Status

17478

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab

Sponsor

IMPULS Endowment Fund